European Society of Cardiology quality indicators for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed in collaboration with the European Heart Rhythm Association of the European Society of Cardiology. Issue 1 (26th August 2022)

• Record Type: Journal Article
• Authors: Aktaa, Suleman; Tzeis, Stylianos; Gale, Chris P; Ackerman, Michael J; Arbelo, Elena; Behr, Elijah R; Crotti, Lia; d'Avila, Andre; de Chillou, Christian; Deneke, Thomas; Figueiredo, Márcio; Friede, Tim; Leclercq, Christophe; Merino, Jose L; Semsarian, Chris; Verstrael, Axel; Zeppenfeld, Katja; Tfelt-Hansen, Jacob; Reichlin, Tobias
• Is Part Of: Europace. Volume 25:Issue 1(2023)
• Page Start: 199
• Page End: 210
• Publication Date: 2022-08-26
• Subjects: Ventricular arrhythmias -- Sudden cardiac death -- Quality indicators -- Treatment -- Accountability -- Clinical practice guidelines -- Outcomes; Arrhythmia -- Treatment -- Periodicals; Cardiac pacing -- Periodicals; Catheter ablation -- Periodicals; Heart -- Physiology -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1093/europace/euac114
• Languages: English
• ISSNs: 1099-5129

Abstract

Abstract: To develop a suite of quality indicators (QIs) for the management of patients with ventricular arrhythmias (VA) and the prevention of sudden cardiac death (SCD). The Working Group comprised experts in heart rhythm management including Task Force members of the 2022 European Society of Cardiology (ESC) Clinical Practice Guidelines for the management of patients with VA and the prevention of SCD, members of the European Heart Rhythm Association, international experts, and a patient representative. We followed the ESC methodology for QI development, which involves (i) the identification of the key domains of care for the management of patients with VA and the prevention of SCD by constructing a conceptual framework of care, (ii) the development of candidate QIs by conducting a systematic review of the literature, (iii) the selection of the final set of QIs using a modified-Delphi method, and (iv) the evaluation of the feasibility of the developed QIs. We identified eight domains of care for the management of patients with VA and the prevention of SCD: (i) structural framework, (ii) screening and diagnosis, (iii) risk stratification, (iv) patient education and lifestyle modification, (v) pharmacological treatment, (vi) device therapy, (vii) catheter ablation, and (viii) outcomes, which included 17 main and 4 secondary QIs across these domains. Following a standardized methodology, we developed 21 QIs for the management of patients with VA and the prevention of SCD. The implementation of these QIs will improve the care and outcomes of patients with VA and contribute to the prevention of SCD.